Background: Addition of probiotics to infant formula may positively affect immune function in nonexclusively breastfed infants. This study aimed to investigate the effect of infant starter formula containing the probiotic Bifidobacterium animalis subspecies lactis (Bb12) on intestinal immunity and inflammation. Methods: Six-week-old healthy, full-term infants (n = 172) were enrolled in a prospective, randomized, double-blind, controlled clinical trial with 2 groups studied in parallel to a breastfed comparison group. Formula-fed (FF) infants were randomized to partially hydrolyzed whey formula (CON) or the same formula containing 106 colony-forming units (CFU) Bb12/g (PRO) for 6 weeks. Fecal secretory IgA (sIgA), calprotectin, lactate, and stool pH were assessed at baseline, 2 weeks, and 6 weeks. Anti-poliovirus-specific IgA and anti-rotavirus-specific IgA were assessed at 2 and 6 weeks. Results: Among vaginally delivered FF infants, PRO consumption increased (P < .05) fecal sIgA compared to CON. Anti-poliovirus-specific IgA concentration increased (P < .05) in all infants consuming PRO, whereas anti-rotavirus-specific IgA tended to increase (P = .056) with PRO consumption in cesarean-delivered infants. Anthropometrics and tolerance did not differ significantly between FF infants. Conclusions: Infants consuming formula with Bb12 produced feces with detectable presence of Bb12 and augmented sIgA concentration. Furthermore, cesarean-delivered infants consuming Bb12 had heightened immune response, as evidenced by increased anti-rotavirus- and anti-poliovirus-specific IgA following immunization. These results demonstrate that negative immune-related effects of not breastfeeding and cesarean delivery can be mitigated by including Bb12 in infant formula, thereby providing infants a safe, dietary, immune-modulating bacterial introduction.
Food and Agriculture Organization (FAO)/World Health Organization (WHO). Health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. Presented at: Amerian Córdoba Park Hotel; October 1-4, 2001; Córdoba, Argentina.
2.
SaavedraJM. Clinical applications of probiotic agents. Am J Clin Nutr. 2001;73:1147S-1151S.
3.
YoshiokaHIsekiKFujitaK. Development and differences of intestinal flora in the neonatal period in breast-fed and bottle-fed infants. Pediatrics. 1983;72:317-321.
4.
SaavedraJMAbi-HannaAMooreNYolkenRH. Long-term consumption of infant formulas containing live probiotic bacteria: tolerance and safety. Am J Clin Nutr. 2004;79:261-267.
5.
ZieglerEEJeterJMDrulisJM. Formula with reduced content of improved, partially hydrolyzed protein and probiotics: infant growth and health. Monatsschrift Kinderheilkunde. 2003;151:65-71.
6.
LanghendriesJPDetryJVan HeesJ. Effect of a fermented infant formula containing viable bifidobacteria on the fecal flora composition and pH of healthy full-term infants. J Pediatr Gastroenterol Nutr. 1995;21:177-181.
7.
BraeggerCChmielewskaADecsiT. Supplementation of infant formula with probiotics and/or prebiotics: a systematic review and comment by the ESPGHAN committee on nutrition. J Pediatr Gastroenterol Nutr. 2011;52:238-250.
8.
FukushimaYKawataYHaraHTeradaAMitsuokaT. Effect of a probiotic formula on intestinal immunoglobulin A production in healthy children. Int J Food Microbiol. 1998;42:39-44.
9.
MohanRKoebnickCSchildtJMuellerMRadkeMBlautM. Effects of Bifidobacterium lactis Bb12 supplementation on body weight, fecal pH, acetate, lactate, calprotectin, and IgA in preterm infants. Pediatr Res. 2008;64:418-422.
10.
WeizmanZAsliGAlsheikhA. Effect of a probiotic infant formula on infections in child care centers: comparison of two probiotic agents. Pediatrics. 2005;115:5-9.
11.
RautavaSSalminenSIsolauriE. Specific probiotics in reducing the risk of acute infections in infancy: a randomised, double-blind, placebo-controlled study. Br J Nutr. 2009;101:1722-1726.
12.
IsolauriEArvolaTSutasYMoilanenESalminenS. Probiotics in the management of atopic eczema. Clin Exp Allergy. 2000;30:1604-1610.
13.
SistekDKellyRWickensKStanleyTFitzharrisPCraneJ. Is the effect of probiotics on atopic dermatitis confined to food sensitized children?Clin Exp Allergy. 2006;36:629-633.
14.
Bakker-ZierikzeeAMTolEAKroesHAllesMSKokFJBindelsJG. Faecal SIgA secretion in infants fed on pre- or probiotic infant formula. Pediatr Allergy Immunol. 2006;17:134-140.
15.
KoutrasAKVigoritaVJ. Fecal secretory immunoglobulin A in breast milk versus formula feeding in early infancy. J Pediatr Gastroenterol Nutr. 1989;9:58-61.
16.
KohlerHDonarskiSStocksBParretAEdwardsCSchrotenH. Antibacterial characteristics in the feces of breast-fed and formula-fed infants during the first year of life. J Pediatr Gastroenterol Nutr. 2002;34:188-193.
17.
ScholtensPAAllietPRaesM. Fecal secretory immunoglobulin A is increased in healthy infants who receive a formula with short-chain galacto-oligosaccharides and long-chain fructo-oligosaccharides. J Nutr. 2008;138:1141-1147.
18.
MullieCYazourhAThibaultH. Increased poliovirus-specific intestinal antibody response coincides with promotion of Bifidobacterium longum-infantis and Bifidobacterium breve in infants: a randomized, double-blind, placebo-controlled trial. Pediatr Res. 2004;56:791-795.
19.
Solano-AguilarGDawsonHRestrepoMAndrewsKVinyardBUrbanJFJr.Detection of Bifidobacterium animalis subsp. lactis (Bb12) in the intestine after feeding of sows and their piglets. Appl Environ Microbiol. 2008;74:6338-6347.
20.
ForchielliMLWalkerWA. The role of gut-associated lymphoid tissues and mucosal defence. Br J Nutr. 2005;93:41-48.
21.
BiasucciGBenenatiBMorelliLBessiEBoehmG. Cesarean delivery may affect the early biodiversity of intestinal bacteria. J Nutr. 2008;138:1796S.
22.
HuurreAKalliomakiMRautavaSRinneMSalminenSIsolauriE. Mode of delivery-effects on gut microbiota and humoral immunity. Neonatology. 2008;93:236-240.
23.
PendersJThijsCVinkC. Factors influencing the composition of the intestinal microbiota in early infancy. Pediatrics. 2006;118:511.
24.
HarmsenHJWildeboer-VelooACRaangsGC. Analysis of intestinal flora development in breast-fed and formula-fed infants by using molecular identification and detection methods. J Pediatr Gastroenterol Nutr. 2000;30:61-67.
25.
RautavaSArvilommiHIsolauriE. Specific probiotics in enhancing maturation of IgA responses in formula-fed infants. Pediatr Res. 2006;60:221.
26.
MoreauMCGaboriau-RouthiauVFullerRPerdigónG. Influence of resident intestinal microflora on the development and functions of the intestinal-associated lymphoid tissue. In: FullerRPerdigónG, eds. Probiotics 3: Immunomodulation by the Gut Microflora and Probiotics. New York: Springer; 2000
27.
MohanRKoebnickCSchildtJ. Effects of Bifidobacterium lactis Bb12 supplementation on intestinal microbiota of preterm infants: a double-blind, placebo-controlled, randomized study. J Clin Microbiol. 2006;44:4025.
28.
KuitunenMKukkonenKJuntunen-BackmanK. Probiotics prevent IgE-associated allergy until age 5 years in cesarean-delivered children but not in the total cohort. J Allergy Clin Immunol. 2009;123:335-341.
29.
PrescottSLMacaubasCHoltBJ. Transplacental priming of the human immune system to environmental allergens: universal skewing of initial T cell responses toward the Th2 cytokine profile. J Immunol. 1998;160:4730.
30.
BuffordJDGernJE. The hygiene hypothesis revisited. Immunol Allergy Clin North Am. 2005;25:247-262.
31.
WengMWalkerWA. Bacterial colonization, probiotics, and clinical disease. J Pediatr. 2006;149:S107-S114.
32.
YazdanbakhshMKremsnerPGvan ReeR. Allergy, parasites, and the hygiene hypothesis. Science. 2002;296:490.
33.
RookGAWBrunetLR. Microbes, immunoregulation, and the gut. Gut. 2005;54:317.
34.
Renz-PolsterHDavidMRBuistAS. Caesarean section delivery and the risk of allergic disorders in childhood. Clin Exp Allergy. 2005;35:1466-1472.
CarrollDCorfieldASpicerRCairnsP. Faecal calprotectin concentrations and diagnosis of necrotising enterocolitis. Lancet. 2003;361:310-311.
37.
KapelNCampeottoFKalachNBaldassareMButelMJDupontC. Faecal calprotectin in term and preterm neonates. J Pediatr Gastroenterol Nutr. 2010;51:542.
38.
CalabreseFSECRViolaSMinieroROR. High faecal calprotectin levels in healthy, exclusively breast-fed infants. Neonatology. 2010;97:299-304.
39.
CampeottoFButelMKalachN. High faecal calprotectin concentrations in newborn infants. Arch Dis Child Fetal Neonat Ed. 2004;89:F353.
40.
DoroskoSMMacKenzieTConnorRI. Fecal calprotectin concentrations are higher in exclusively breastfed infants compared to those who are mixed-fed. Breastfeeding Med. 2008;3:117-119.
41.
GoldenBBunnSMainM. Age-dependent variations in fecal calprotectin concentrations in children. J Pediatr Gastroenterol Nutr. 2002;34:324.
42.
OlafsdottirEAksnesLFlugeGBerstadA. Faecal calprotectin levels in infants with infantile colic, healthy infants, children with inflammatory bowel disease, children with recurrent abdominal pain and healthy children. Acta Paediatrica. 2002;91:45-50.
43.
RhoadsJMFathereeNYNororiJ. Altered fecal microflora and increased fecal calprotectin in infants with colic. J Pediatr. 2009;155:823-828. e1.
44.
RugtveitJFagerholMK. Age-dependent variations in fecal calprotectin concentrations in children. J Pediatr Gastroenterol Nutr. 2002;34:323.
45.
KukkonenKKuitunenMHaahtelaTKorpelaRPoussaTSavilahtiE. High intestinal IgA associates with reduced risk of IgE-associated allergic diseases. Pediatr Allergy Immunol. 2010;21:67-73.
